OTCMKTS:SPHRY

Starpharma Holdings Stock Earnings Reports

etoro logo Buy SPHRY
*Your capital is at risk
$5.00
+0 (+0%)
At Close: Jun 22, 2026

Starpharma Holdings Earnings Calls

Dec 31, 2025
Release date Feb 24, 2026
EPS estimate -
EPS actual $0.0214
Revenue estimate -
Revenue actual 7.096M
Jun 30, 2025
Release date Aug 25, 2025
EPS estimate -
EPS actual -$0.0360
Revenue estimate -
Revenue actual 1.121M
Dec 31, 2024
Release date Feb 26, 2025
EPS estimate -
EPS actual -$0.0802
Revenue estimate -
Revenue actual 1.502M
Sep 30, 2024
Release date Oct 30, 2024
EPS estimate -
EPS actual -
Revenue estimate -
Revenue actual -

Last 4 Quarters for Starpharma Holdings

Below you can see how SPHRY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sep 30, 2024
Release date Oct 30, 2024
Price on release $0.630
EPS estimate -
EPS actual -
Date Price
Oct 24, 2024 $0.620
Oct 25, 2024 $0.620
Oct 28, 2024 $0.633
Oct 29, 2024 $0.630
Oct 30, 2024 $0.630
Oct 31, 2024 $0.595
Nov 01, 2024 $0.610
Nov 04, 2024 $0.665
Nov 05, 2024 $0.670
4 days before 1.61%
4 days after 6.35%
On release day -5.56%
Change in period 8.06%
Dec 31, 2024
Release date Feb 26, 2025
Price on release $0.750
EPS estimate -
EPS actual -$0.0802
Date Price
Feb 20, 2025 $0.751
Feb 21, 2025 $0.750
Feb 24, 2025 $0.750
Feb 25, 2025 $0.750
Feb 26, 2025 $0.750
Feb 27, 2025 $0.750
Feb 28, 2025 $0.750
Mar 03, 2025 $0.750
Mar 04, 2025 $0.750
4 days before -0.140%
4 days after 0%
On release day 0%
Change in period -0.140%
Jun 30, 2025
Release date Aug 25, 2025
Price on release $0.748
EPS estimate -
EPS actual -$0.0360
Date Price
Aug 19, 2025 $0.752
Aug 20, 2025 $0.93
Aug 21, 2025 $0.93
Aug 22, 2025 $0.93
Aug 25, 2025 $0.748
Aug 26, 2025 $0.782
Aug 27, 2025 $0.797
Aug 28, 2025 $0.89
Aug 29, 2025 $0.82
4 days before -0.532%
4 days after 9.41%
On release day 4.56%
Change in period 8.83%
Dec 31, 2025
Release date Feb 24, 2026
Price on release $3.40
EPS estimate -
EPS actual $0.0214
Date Price
Feb 18, 2026 $3.55
Feb 19, 2026 $3.55
Feb 20, 2026 $3.60
Feb 23, 2026 $3.40
Feb 24, 2026 $3.40
Feb 25, 2026 $3.35
Feb 26, 2026 $3.15
Feb 27, 2026 $3.15
Mar 02, 2026 $3.15
4 days before -4.23%
4 days after -7.35%
On release day -1.47%
Change in period -11.27%

Starpharma Holdings Earnings History

Earnings Calendar

FAQ

When is the earnings report for SPHRY?
Starpharma Holdings Limited (SPHRY) has scheduled its earnings report for Aug 26, 2026 after the markets close.

What is the SPHRY price-to-earnings (P/E) ratio?
SPHRY P/E ratio as of Jun 22, 2026 (TTM) is -90.26.

What is the SPHRY EPS forecast?
The forecasted EPS (Earnings Per Share) for Starpharma Holdings Limited (SPHRY) for the first fiscal quarter 2026 is $.

What are Starpharma Holdings Limited's retained earnings?
On its balance sheet, Starpharma Holdings Limited reported retained earnings of $7.66 million for the latest quarter ending Dec 30, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT STARPHARMA HOLDINGS LIMITED
Starpharma Holdings
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE